Medindia

X

Idenix Pharmaceuticals to Present at the JP Morgan 27th Annual Healthcare Conference

Monday, January 5, 2009 General News J E 4
Advertisement
CAMBRIDGE, Mass., Jan. 5 Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the upcoming JP Morgan 27th Annual Healthcare Conference on Wednesday, January 14, 2009 at 7:30 a.m. PT at the Westin St. Francis Hotel in San Francisco.



The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replays will be available on the Idenix website for two weeks following the conference.



About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus and HIV. For further information about Idenix, please refer to www.idenix.com.





Idenix Pharmaceuticals' Contacts: Media: Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838

SOURCE Idenix Pharmaceuticals, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Prism Pharmaceuticals Receives FDA Approval of NEX...
S
Despite Availability of Generic Equivalents, Two-T...